Blog
RSS FeedPosted by Michael Wonder on 16 Apr 2025
Eli Lilly issues warning for Australia as Trump signals pharma tariffs
15 April 2025 - Eli Lilly says it could pull tens of millions of dollars invested in Australian clinical trials unless ...
Posted by Michael Wonder on 11 Apr 2025
13,000 people to benefit from new insulin medicine
11 April 2025 - Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from ...
Posted by Michael Wonder on 10 Apr 2025
Pfizer wins Korea nod for paediatric arthritis use of oral JAK inhibitor Xeljanz
7 April 2025 - Pfizer Korea has won national reimbursement for its oral JAK inhibitor Xeljanz (tofacitinib), expanding access to ...
Posted by Michael Wonder on 10 Apr 2025
PHARMAC to fund medicines for blood cancers, inflammatory bowel disease, eczema and arthritis
10 April 2025 - More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, ...
Posted by Michael Wonder on 07 Apr 2025
Rule of Two for faster access to medicines
3 April 2025 - Associate Health Minister David Seymour is welcoming Cabinet’s decision to enable medicines to be approved in ...
Posted by Michael Wonder on 04 Apr 2025
Janssen Korea’s Zytiga secures expanded reimbursement for first-line prostate cancer treatment
2 April 2025 - Beginning in April, Janssen Korea's prostate cancer drug Zytiga will be available with prednisolone as a ...
Posted by Michael Wonder on 03 Apr 2025
GSK Korea's long-acting HIV injection therapy gains insurance benefit
1 April 2025 - GSK Korea said its long-acting injectable HIV-1 combination treatment, Vocabria (cabotegravir 600 mg) and Rekambys (rilpivirine ...
Posted by Michael Wonder on 02 Apr 2025
Sanofi launches new cholesterol lowering injection in Korea with health insurance coverage
1 April 2025 - Sanofi Korea announced the launch of Praluent Pen 300 mg (alirocumab) today following its inclusion in ...
Posted by Michael Wonder on 02 Apr 2025
Doctors push for weight loss drugs to be added to the PBS
1 April 2025 - The cost of prescriptions for weight loss drugs is being brought into question, with doctors pushing ...
Posted by Michael Wonder on 31 Mar 2025
PHARMAC proposing to fund two brands of oestradiol patches
27 March 2025 - PHARMAC is seeking feedback on a proposal to fund two brands of oestradiol patches for New ...
Posted by Michael Wonder on 27 Mar 2025
ViiV Healthcare announces reimbursement for Apretude for HIV-1 pre-exposure prophylaxis under the Non-Insured Health Benefits (NIHB) Program
25 March 2025 - ViiV Healthcare is pleased to announce that Apretude (cabotegravir tablets and extended release injectable suspension) is ...
Posted by Michael Wonder on 27 Mar 2025
New and expanded cheaper medicines
27 March 2025 - Australians with Cushing’s syndrome, retinal vein occlusion and psoriatic arthritis, leukaemia, and women needing contraception and menopause ...
Posted by Michael Wonder on 25 Mar 2025
Government of Canada signs bilateral agreement with Quebec for Drugs for Rare Diseases
21 March 2025 - In Canada, one in 12 people live with a rare disease, and for most people affected, the ...
Posted by Michael Wonder on 20 Mar 2025
Global pharma gives up reimbursement in Korea, and this is a serious concern
19 March 2025 - "We believe convincing our headquarters is no longer feasible, and we have no plans to apply ...
Posted by Michael Wonder on 18 Mar 2025
Pfizer's Ixifi will be available in Canada as of 1 April 2025
17 March 2025 - Ixifi is available in more than 20 countries and was approved by Health Canada in December 2021. ...